{"id":"raclopride-c11","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2104769","moleculeType":"Small molecule","molecularWeight":"346.24"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Raclopride C11 binds competitively to dopamine D2 and D3 receptors in the brain and is labeled with the radioactive isotope carbon-11, allowing visualization and quantification of dopamine receptor density and occupancy via PET imaging. It is used as a diagnostic tool to assess dopaminergic neurotransmission in research and clinical settings, particularly in neuropsychiatric and neurodegenerative disorders.","oneSentence":"Raclopride C11 is a dopamine D2/D3 receptor antagonist labeled with carbon-11 for use as a positron emission tomography (PET) imaging agent.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:03:37.083Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"PET imaging of dopamine D2/D3 receptor density in the brain for research and diagnostic purposes"}]},"trialDetails":[{"nctId":"NCT03190954","phase":"EARLY_PHASE1","title":"Brain Dopaminergic Signaling in Opioid Use Disorders","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2017-08-17","conditions":"Normal Physiology, Opioid Use Disorders","enrollment":153},{"nctId":"NCT06977308","phase":"PHASE1","title":"A Multimodal Imaging Study of Dopamine in Early Psychosis","status":"NOT_YET_RECRUITING","sponsor":"New York State Psychiatric Institute","startDate":"2026-03-01","conditions":"Clinical High Risk for Psychosis (CHR)","enrollment":115},{"nctId":"NCT07213219","phase":"NA","title":"PET-MRI of Reward System in Parkinson's Disease With RBD","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2026-01-01","conditions":"Parkinson's Disease (PD)","enrollment":44},{"nctId":"NCT02169310","phase":"PHASE1","title":"Neural Basis of Decision-Making Deficits in Traumatic Brain Injury","status":"COMPLETED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2014-11-18","conditions":"Traumatic Brain Injury","enrollment":45},{"nctId":"NCT05282277","phase":"PHASE4","title":"Examining the Effects of Estradiol on Neural and Molecular Response to Reward","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-04-20","conditions":"Depression, Psychosis, Anhedonia","enrollment":103},{"nctId":"NCT06299410","phase":"PHASE1","title":"PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects","status":"RECRUITING","sponsor":"Intra-Cellular Therapies, Inc.","startDate":"2024-04-11","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT03326245","phase":"PHASE1","title":"Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2018-01-29","conditions":"Normal Physiology","enrollment":25},{"nctId":"NCT03637075","phase":"NA","title":"Raclopride-PET/MRT","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"2017-02-20","conditions":"Diabetes Mellitus, Type 2","enrollment":24},{"nctId":"NCT05359887","phase":"NA","title":"PET-study on the Role of the Reward System in Weight Loss After Bariatric Surgery","status":"RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2022-12-01","conditions":"Obesity","enrollment":30},{"nctId":"NCT02233829","phase":"EARLY_PHASE1","title":"Dopamine Rhythms in Health and Addiction","status":"WITHDRAWN","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2024-04-23","conditions":"Cocaine Abuse","enrollment":""},{"nctId":"NCT03648892","phase":"EARLY_PHASE1","title":"Brain Dopamine Function in Human Obesity","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2018-09-21","conditions":"Obesity, Healthy Volunteers, Overweight","enrollment":61},{"nctId":"NCT02152670","phase":"NA","title":"Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET","status":"TERMINATED","sponsor":"Yale University","startDate":"2014-05","conditions":"Cocaine Dependence","enrollment":1},{"nctId":"NCT03026036","phase":"","title":"Neuroimaging Studies of Reward Processing in Depression","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2016-04","conditions":"Major Depressive Disorder","enrollment":123},{"nctId":"NCT00716755","phase":"NA","title":"Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2009-10","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder","enrollment":45},{"nctId":"NCT03999190","phase":"","title":"Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2019-07","conditions":"Schizophrenia","enrollment":""},{"nctId":"NCT02333487","phase":"PHASE1","title":"Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2014-12-30","conditions":"Schizophrenia","enrollment":22},{"nctId":"NCT02020408","phase":"PHASE4","title":"Monoamine Contributions to Neurocircuitry in Eating Disorders","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2011-05","conditions":"Eating Disorder","enrollment":88},{"nctId":"NCT00825045","phase":"NA","title":"Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia","status":"UNKNOWN","sponsor":"Centre for Addiction and Mental Health","startDate":"2008-12","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder","enrollment":14},{"nctId":"NCT02225106","phase":"PHASE2","title":"Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2014-08-06","conditions":"Cognition Disorder, Attention Deficit Disorder, Traumatic Brain Injury","enrollment":11},{"nctId":"NCT02148783","phase":"PHASE2","title":"Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI","status":"TERMINATED","sponsor":"Uniformed Services University of the Health Sciences","startDate":"2014-09","conditions":"Traumatic Brain Injury","enrollment":11},{"nctId":"NCT00953745","phase":"NA","title":"Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2009-05","conditions":"Major Depressive Disorder","enrollment":43},{"nctId":"NCT00024960","phase":"","title":"Dopamine Function in Developmental Stuttering","status":"COMPLETED","sponsor":"National Institute on Deafness and Other Communication Disorders (NIDCD)","startDate":"2001-10-03","conditions":"Developmental Stuttering","enrollment":12},{"nctId":"NCT00401999","phase":"","title":"OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2006-11-16","conditions":"Alcoholism","enrollment":35},{"nctId":"NCT00015301","phase":"PHASE4","title":"Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2003-12","conditions":"Cocaine-Related Disorders, Substance-Related Disorders","enrollment":""},{"nctId":"NCT02061722","phase":"EARLY_PHASE1","title":"[PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET.","status":"COMPLETED","sponsor":"CHDI Foundation, Inc.","startDate":"2013-01","conditions":"Huntington's Disease","enrollment":90},{"nctId":"NCT00670293","phase":"","title":"Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2008-07","conditions":"Eating Disorders","enrollment":50},{"nctId":"NCT00392743","phase":"","title":"A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12","conditions":"Schizophrenia","enrollment":60},{"nctId":"NCT00818298","phase":"NA","title":"24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2009-01","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":12},{"nctId":"NCT00396669","phase":"NA","title":"A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2007-07","conditions":"Tobacco Use Disorder","enrollment":24},{"nctId":"NCT00846339","phase":"PHASE4","title":"PET Imaging Study on Occupancy of Dopamine D2 Receptors and Genotypes After Bupropion Administration","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2008-11","conditions":"Smoking","enrollment":12},{"nctId":"NCT00832221","phase":"PHASE1","title":"Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUEL","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-01","conditions":"Depression","enrollment":10},{"nctId":"NCT00480246","phase":"PHASE1","title":"A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer","status":"COMPLETED","sponsor":"BioLineRx, Ltd.","startDate":"2007-05","conditions":"Healthy","enrollment":""},{"nctId":"NCT00562198","phase":"PHASE2","title":"PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding","status":"TERMINATED","sponsor":"Orion Corporation, Orion Pharma","startDate":"2008-01","conditions":"Parkinson´s Disease","enrollment":16},{"nctId":"NCT00050219","phase":"","title":"Role of Dopamine in Response to Alcohol","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2002-11","conditions":"Alcohol Consumption","enrollment":60},{"nctId":"NCT00032812","phase":"","title":"The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2002-03","conditions":"Parkinson Disease, Healthy","enrollment":64}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["[C11]Raclopride"],"phase":"marketed","status":"active","brandName":"Raclopride C11","genericName":"Raclopride C11","companyName":"University of North Carolina, Chapel Hill","companyId":"university-of-north-carolina-chapel-hill","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Raclopride C11 is a dopamine D2/D3 receptor antagonist labeled with carbon-11 for use as a positron emission tomography (PET) imaging agent. Used for PET imaging of dopamine D2/D3 receptor density in the brain for research and diagnostic purposes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}